Voyager Therap (VYGR)
Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706,...
- Open
- 3.420
- High
- 3.480
- Low
- 3.350
- Prev. Close
- 3.450
- Volume
- 461.28K
- Turnover
- 1.58M
- Avg Price
- 3.432
- Bid/Ask Ratio
- --
- Amplitude
- 3.77%
- 52wk High
- 5.550
- Volume Ratio
- 0.60
- Turnover Ratio
- 1.04%
Voyager Therap Analyst Rating
View moreForecast & Rating
Aug 27, 2026Price forecast
$14.89334.08%
Forecast & RatingStrong buy
11analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Simplywall · Aug 12 at 11:41 AM
Analysts Have Just Cut Their Voyager Therapeutics, Inc. (NASDAQ:VYGR) Revenue Estimates By 47%
- Tip Ranks · Aug 7 at 08:08 AM
TD Cowen Remains a Buy on Voyager Therapeutics (VYGR)
- Earnings Watch · Aug 7 at 03:14 AM
Voyager Therap | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 3.165 M
